(Hypertension. 1997;29:918-922.)
© 1997 American Heart Association, Inc.
Articles |
From Duke University Medical Center, Durham, NC (L.P.S., Y.-T.C., L.P.); Louisiana State University Medical Center (S.P.M.), New Orleans; and National Institutes of Health, National Center for Human Genome Research, Baltimore, Md (A.F.W.).
| Abstract |
|---|
|
|
|---|
2c10-adrenergic receptor genes. A total of 109 sib pairs
was evaluated. Salt sensitivity was defined as the change in blood
pressure in each individual, comparing the sodium-loaded with the
volume-depleted state. Systolic pressure decreased by an average of
9.0±9%, diastolic pressure by 1.5±11%, and mean arterial pressure
by 5.0±9%. Neither blood pressure nor salt sensitivity was linked at
the
2c10-adrenergic receptor locus. No evidence
suggested that systolic salt sensitivity and baseline blood pressure
were linked at the ß2-adrenergic receptor locus.
Model-independent sib pair linkage analysis suggested that diastolic
blood pressure response to sodium loading/volume depletion is linked at
the ß2-adrenergic receptor locus (P<.006).
Evidence for linkage was significant at the .05 level after adjustment
for the number of phenotypic traits examined.
Key Words: blacks hypertension, genetic genetics sodium
| Introduction |
|---|
|
|
|---|
Salt sensitivity, like hypertension, has a relatively high heritable
component and can be treated as a qualitative or quantitative
trait.2 3 4 5 A number of regulatory mechanisms could
potentially lead to salt sensitivity, such as sodium excretion,
vascular reactivity, or both. Genes that influence these phenomena can
be considered to be candidate genes for salt sensitivity. Genes
encoding two adrenergic receptors (ADRs) were investigated. The
ß2-ADR gene, found on chromosome 5q31-32, regulates
vascular smooth muscle relaxation. The
2-ADR genes are
involved in the regulation of vascular smooth muscle contraction,
sodium excretion, and renin release. The
2-ADR gene we
investigated is located on chromosome 10q24-26 (
2c10).
In this study, we used model-independent sib pair methods to test for
linkage of the salt sensitivity phenotype in blacks with genotype at
the ß2- and
2c10-ADR loci.
| Methods |
|---|
|
|
|---|
Ascertainment and Eligibility
Black families were ascertained through a single proband with
hypertension, followed by sequential ascertainment of all available
adult siblings (with or without hypertension) among the first-,
second-, and third-degree relatives of the proband. We phenotyped and
genotyped all sib pairs and genotyped all available parents of the sib
pairs.
Subjects were excluded from the study if they were less than 18 years of age. In addition, subjects were excluded if they had a history of malignant or accelerated hypertension, if their diastolic BP was greater than 120 mm Hg, if there was a contraindication to discontinuing BP medications, or if they had a history of furosemide allergy. Subjects were also excluded if they showed evidence of impaired renal function (ie, serum creatinine >1.5 mg/dL [133 µmol/L], urinary protein excretion >500 mg/d, or active urinary sediment). Other exclusion criteria were myocardial infarction, cerebrovascular accident, or transient ischemic attack within the previous 6 months; congestive heart failure by history, physical examination, or chest radiograph; volume depletion; severe peripheral vascular disease; or inability to give informed consent or comply with the study protocol.
To confirm that reported parent-offspring relationships were biological, we typed parents and offspring with a battery of red blood cell markers and antigens designed to detect at least 70% of mistaken parentage.6 7 Subjects in whom biological parentage could not be confirmed were excluded from the analysis.
Data collected included demographic characteristics, anthropometric measurements, and plasma renin activity by radioimmunoassay. Dietary intake of sodium and potassium was estimated from 24-hour urinary excretion rates.
We performed salt sensitivity phenotyping at the Duke Clinical Research Unit using the intravenous sodium-loading/furosemide volume-depletion protocol of Grim et al.4 BP medication was tapered and discontinued at least 2 weeks before this evaluation.
Sodium Chloride Loading
After baseline BP measurements, normal saline (0.9%) was
infused via the brachial vein at a rate of 2 L over 4 hours (8
AM to noon). The total sodium intake during this 24-hour
period (intravenous plus dietary) was approximately 500 mEq (11 500
mg). Dietary potassium intake was 70 mEq/d (2730 mg/d).
Volume Depletion
Starting at 8 AM on the day after sodium loading,
dietary sodium intake was limited to 10 mEq (230 mg). Dietary potassium
remained at 70 mEq (2730 mg/d), and subjects were allowed no more than
25 mL water/kg. Body weight, height, and skinfold thickness were used
for estimation of lean body weight. Furosemide was then administered at
a dose of 1 mg/kg lean body wt (maximum, 120 mg), divided into three
oral doses over the day. This dose differs slightly from the original
protocol of Grim et al,4 which used 120 mg lasix in all
subjects. This modification was made for safety purposes and to
normalize the diuresis so that it was equivalent to 120 mg furosemide
in a 70-kg individual. Each subject was weighed before the second
furosemide dose. If weight loss due to diuresis exceeded 3% of
baseline (total) body weight, the third furosemide dose was reduced to
avoid symptomatic hypotension.
BP Measurements
BP was measured by trained and certified personnel8
before the onset of saline infusion (baseline), at the end of saline
infusion (sodium-loaded), and 24 hours after the first furosemide dose
(volume-depleted). Each BP measurement consisted of the average of two
seated measurements made with a mercury sphygmomanometer using the same
arm and an appropriately sized cuff. Subjects were seated for at least
5 minutes before each BP recording. In addition, for safety purposes,
BP was measured every hour throughout the saline-loading and
volume-depletion procedures.
The sodium-loading procedure was terminated before completion if systolic BP exceeded 180 mm Hg, if diastolic BP exceeded 120 mm Hg, or if symptoms related to elevated BP or volume expansion developed. The volume-depletion procedure was terminated before completion if the subject developed symptomatic hypotension. If the procedure was terminated before completion, the last BP before termination was used in the salt sensitivity calculations. One individual prematurely terminated the salt sensitivity procedure.
Interpretation
Baseline BP was defined as the average of the two seated
measurements taken just before the onset of sodium infusion. As
previously reported by Grim et al,4 salt sensitivity was
defined as the continuous variables representing the decrease in
systolic, diastolic, and mean arterial pressures going from the
sodium-loaded to the volume-depleted state. The decrease in pressure
was expressed as a percentage of the sodium-loaded pressure; similar
salt sensitivity results were obtained when absolute values were used.
Salt sensitivity was calculated from the formula [(BPsodium
loaded-BPvolume depleted)/BPsodium
loaded]x100. Mean arterial pressure was calculated from the
formula [(2xDiastolic BP)+Systolic BP]/3.
Genetic Analysis
Genomic DNA was extracted from leukocytes in whole blood and
digested with restriction enzymes that had been previously reported to
reveal polymorphisms of the ß2- and
2c10-ADR genes.9 10 Probes for the
full-length coding sequences were provided by Dr Robert Lefkowitz (Duke
University Medical Center). Restriction fragment length polymorphisms
were identified by Southern blot. Genotyping methods are described
elsewhere.11
Statistical Analysis
We used the Haseman-Elston sib-pair test to perform linkage
analysis as implemented in SIBPAL (SAGE, 1994).12 In the
Haseman-Elston test, information from both the siblings' and their
parents' marker genotypes is used to estimate, with Bayesian methods,
the proportion of alleles each sib pair shares identical-by-descent
(IBD) at the marker locus. In the case of the candidate gene approach,
the candidate gene is itself the marker locus. For quantitative traits,
the squared sib pair trait difference, in this case the difference in
the degree of salt sensitivity, is regressed on the estimated
proportion of alleles each sib pair shares IBD at the candidate/marker
locus or a locus tightly linked to it. If the candidate locus is
responsible for at least some of the variation in the degree of salt
sensitivity, siblings with an estimated proportion of alleles IBD that
is high (ie, they are more likely to be concordant at the
candidate/marker locus) should also be similar phenotypically (ie, they
should have a similar degree of salt sensitivity and thus a small
squared sib pair trait difference). In this case, the slope of the
regression line will be negative. On the other hand, if the
candidate/marker locus or a locus tightly linked to it is not involved
in the variation of salt sensitivity, there will be no change in salt
sensitivity with respect to the estimated proportion of alleles IBD,
and the slope of the regression will be zero. The P value
indicates the probability that the observed (or a greater) slope would
occur if the "true" slope were zero.
In the present study, we used parental genotype data to estimate the
proportion of alleles IBD when these data were available and
informative. When parental genotyping was not available, we used
population gene frequencies obtained from 96 unrelated black Americans
who had been previously genotyped at the ß2- and
2c10-ADR loci.2
The inclusion of covariate information may be critical in identifying genetic components, especially if the covariate has a substantial effect on the phenotype. We used Pearson product-moment correlation coefficients to test for relationships between salt sensitivity and BP-related variables such as age, body composition, and plasma renin activity. Variables significantly correlated with salt sensitivity were included in an adjusted sib-pair analysis.
| Results |
|---|
|
|
|---|
Baseline characteristics of participating siblings are presented in
Table 1
. The mean age was 37 years (range, 19 to 58),
70% of participants were female, and 33% had hypertension.
|
Systolic, diastolic, and mean arterial BPs at baseline (ie, before
saline infusion) are presented in Table 2
. As noted
above, our definition of salt sensitivity was the decrease in BP going
from the saline-loaded state (ie, at the end of the saline infusion) to
the volume-depleted state (ie, 24 hours after the first furosemide
dose). Table 2
indicates that systolic pressure decreased by an average
of 9.0±9%, diastolic pressure by 1.5±11%, and mean arterial
pressure by 5.0±9%. Thirty-three percent of participants had at least
a 10% decrease in mean arterial pressure and therefore would be
classified as salt sensitive.1
|
There was no significant correlation between salt sensitivity and baseline BP, weight, body mass index, urinary sodium excretion, or urinary potassium excretion. The effect of the disproportionate enrollment of women in this study was presumably minimal because salt sensitivity and sex were not significantly correlated. As previously demonstrated,13 salt sensitivity was significantly correlated with age (r=.33, P=.0005); therefore, linkage analyses were performed with and without age adjustment. Results with and without this adjustment were essentially identical.
Table 3
shows the results of the age-adjusted sib-pair
linkage analysis. There was no evidence of linkage between any trait
and the
2c10-ADR locus. At the ß2-ADR
locus, there was no evidence of linkage with baseline pressure or
systolic salt sensitivity. In contrast, the linkage analysis suggests
that diastolic pressure response to the sodium-loading/volume-depletion
maneuver was linked at the ß2-ADR locus
(P<.006). Evidence for linkage was significant at the .05
level after adjustment for the number of traits examined (ie, baseline
mean arterial pressure and systolic, diastolic, and mean arterial salt
sensitivity).
|
| Discussion |
|---|
|
|
|---|
The heritability estimates of salt sensitivity, ie, the proportion of the phenotypic variance that can be attributed to additive genetic effects, ranges from .34 to as high as .84 in whites3 and blacks2 (and C.E. Grim, personal communication), similar to the heritability of BP itself.15 16
The mechanism by which salt sensitivity might lead to sustained BP
elevation is unclear despite abundant data implicating salt intake in
the development of hypertension. Salt sensitivity is attributed to a
renal defect in sodium excretion, but salt-sensitive individuals do not
continuously expand their intravascular volume. Therefore, several
hypotheses have attempted to explain the connection between salt
sensitivity and the hallmark of essential hypertension, increased
peripheral vascular resistance. One tenable hypothesis is that salt
sensitivity represents an altered responsiveness of both the kidneys
and vasculature to circulating or local factors that regulate sodium
excretion and vascular tone.17 Such altered responsiveness
has been demonstrated in experimental18 and
human19 20 21 22 23 salt sensitivity. The importance of the ADRs in
vascular reactivity and renal sodium excretion provided the rationale
for our investigation of the ß2- and
2c10-ADRs as candidate genes. Preliminary evidence of
linkage at the ß2-ADR locus was observed.
ß2-ADRs are implicated in hypertension and salt sensitivity in studies suggesting deficient ß-mediated vasorelaxation.24 For instance, salt loading in salt-sensitive men is associated with increased vascular resistance25 26 27 and failure to decrease vasoconstrictor responses to angiotensin II.22 Two additional human studies suggest increased ß2-ADR sensitivity and density in blacks with hypertension28 and in individuals who show a pressor response to sodium loading.29 These findings may help explain the clinical observation that ß-blockers are less effective in lowering BP in blacks than in whites, but they are seemingly inconsistent with a hypothesis suggesting impaired ß-mediated vasodilation. However, in these studies, receptor density and function were evaluated in lymphocytes28 and skin fibroblasts,29 which may or may not reflect conditions in tissues involved in BP regulation. Although we have not evaluated receptor density, sensitivity, or function in our subjects, our observations are consistent with our previous findings of an association between genotype at this locus and the presence or absence of hypertension in unrelated blacks.11 Should evidence of linkage at this locus be confirmed by subsequent human studies, the functional correlates will need further exploration.
Although our sample size is small, these data suggest that the diastolic response to sodium loading and volume depletion is linked to the ß2-ADR locus. On average, diastolic BP changed little in response to the salt sensitivity maneuver (mean 1.5% decline), perhaps suggesting that the observed linkage is not clinically significant. However, the diastolic BP response ranged from a decrease of 24% to an increase of 20%, suggesting the possibility of heterogeneity of this response and thus the possibility of genetic heterogeneity. The lack of linkage of the systolic response may be consistent with data suggesting that systolic and diastolic BPs are under independent genetic influences.30
An alternative interpretation of our data is that the ß2-ADR locus is simply a marker for a salt sensitivity gene in that general region of chromosome 5 but does not itself play a role in the variation of salt sensitivity. A role for the ß2-ADR locus in the expression of salt sensitivity will require replication and subsequent confirmation of linkage with additional markers in that chromosomal region. Ultimately, the identification of variants at that locus that lead to altered receptor function will be necessary to confirm (or refute) the role of the ß2-ADR locus.
We noted no linkage of salt sensitivity at the
2c10-ADR
locus. This is somewhat surprising in light of the location and
function of these receptors.
2-Receptors are located on
vascular smooth muscle cells and various cell types in the kidney and
are known to influence vascular tone (both systemic and renal),
proximal tubular sodium reabsorption, and renin release.31
However, several studies have failed to demonstrate an association of
the
2c10-ADR with hypertension,32 33
although one report demonstrates an association in
blacks.34 In previous work, we noted an association of
2c10 with hypertension in whites only and not in
blacks.11 Thus, the role of the
2c10-ADR
locus in salt sensitivity and hypertension remains unclear.
We designed this study to test a specific hypothesis concerning two ADR loci, requiring a focused and narrow approach to genotyping. A broader strategy for discovering salt sensitivity and hypertension genes, currently in progress in our laboratory, involves genomic screening. In this approach, polymorphic markers spanning the entire human genome are used to identify regions of linkage between hypertension and salt sensitivity traits and markers distributed throughout the human genome. Both approaches can be used to dissect out the genetic components underlying salt sensitivity and hypertension. The current use of the candidate gene approach provides preliminary evidence of linkage of diastolic salt sensitivity at the ß2-ADR locus.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received October 4, 1996; first decision October 11, 1996; accepted October 11, 1996.
| References |
|---|
|
|
|---|
2.
Svetkey LP, McKeown SP, Wilson AF. Heritability
of salt sensitivity in black Americans.
Hypertension. 1996;28:854-858.
3.
Miller JZ, Weinberger MH, Christian JC, Daugherty
SA. Familial resemblance in the blood pressure response to
sodium restriction. Am J Epidemiol. 1987;126:822-830.
4.
Grim CE, Miller JZ, Luft FC, Christian JC, Weinberger
MH. Genetic influences on renin, aldosterone, and the renal
excretion of sodium and potassium following volume expansion and
contraction in normal man. Hypertension. 1979;1:583-590.
5. Whitfield JB, Martin NG. Genetic and environmental causes of variation in renal tubular handling of sodium and potassium: a twin study. Gen Epidemiol. 1985;2:17-27.
6. Widmann F, ed. Technical Manual of the American Association of Blood Banks. 9th ed. Arlington, Va: American Association of Blood Banks; 1985: chaps 8-10.
7. Silver H, ed. Paternity Testing. Arlington, Va: American Association of Blood Banks; 1978: chap 3.
8. Sacks FM, Obarzanek E, Windhauser MM, Svetkey LP, Vollmer W, McCullough M, Karanja N, Lin P-H, Proschan MA, Appel LJ, Bray GA, Vogt TM, Moore TJ, for the DASH investigators. Rationale and design of the dietary approaches to stop hypertension trial (DASH): a multicenter controlled feeding study of dietary patterns associated with lower blood pressure. Ann Epidemiol. 1995;5:108-118. [Medline] [Order article via Infotrieve]
9.
Lentes K-U, Berrettini WH, Hoehe MR, Chung F-Z,
Gershon ES. A biallelic DNA polymorphism of the human
beta2-adrenergic receptor detected by Ban I-Adrbr-2.
Nucleic Acids Res. 1988;16:2359.
10.
Hoehe MR, Berrettini WH, Lentes K-U. Dra I
identifies a two allele DNA polymorphism in the human alpha2-adrenergic
receptor gene (ADRAR), using a 5.5 kb probe (p ADRAR).
Nucleic Acids Res. 1988;16:9070.
11.
Svetkey LP, Timmons PZ, Emovon O, Anderson NB, Preis L,
Chen Y-T. Association of hypertension with ß2- and
2c10-adrenergic receptor genotype.
Hypertension. 1996;27:1210-1215.
12. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus. Am J Hum Genet. 1993;52:506-516. [Medline] [Order article via Infotrieve]
13.
Weinberger MH, Fineberg NS. Sodium and volume
sensitivity of blood pressure: age and pressure change over
time. Hypertension. 1991;18:67-71.
14.
Lander ES, Schork NJ. Genetic dissection of
complex traits. Science. 1994;265:2037-2048.
15. McIhany ML, Shaffer JW, Hines EA. The heritability of blood pressure: an investigation of 200 twin pairs using the cold pressure test. Johns Hopkins Med J. 1975;136:57-74. [Medline] [Order article via Infotrieve]
16.
Feinleib M, Garrison RJ, Fabsitz R, Christian JC,
Hrubec Z, Borhani NO, Kannel WB, Rosenman R, Schwartz JT, Wagner
JO. The NHLBI twin study of cardiovascular disease risk factors:
methodology and summary of results Am J
Epidemiol. 1977;106:284-295.
17. Aviv A, Aladjem M. Essential hypertension in blacks: epidemiology, characteristics, and possible roles of racial differences in sodium, potassium and calcium regulation. Cardiovasc Drugs Ther. 1990;4:335-342.
18.
Rapp JP. Dahl salt-susceptible and
salt-resistant rats: a review. Hypertension. 1982;4:753-763.
19. Mark AL, Lawton WJ, Abboud FM, Fitz AE, Connor WE, Heistad DD. Effects of high and low sodium intake on arterial pressure and forearm vascular resistance in borderline hypertension: a preliminary report. Circ Res. 1975;36(suppl I):I-195-I-198.
20. Sullivan JM, Prewitt RL, Ratts TE. Sodium sensitivity in normotensive and borderline hypertensive humans. Am J Med Sci. 1988;295:370-377. [Medline] [Order article via Infotrieve]
21. Koolen MI, Bussemaker-Verduyn den Boer E, van Brummelen P. Clinical, biochemical, and haemodynamic correlates of sodium sensitivity in essential hypertension. J Hypertens. 1983;1(suppl 2):21-23.
22. Egan BM, Petrin J, Hoffmann RG. NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men. Am J Hypertens. 1991;4:924-931. [Medline] [Order article via Infotrieve]
23. Campese VM, Romoff MS, Levitan J, Saglikes Y, Friedlier R, Massry SG. Abnormal relationship between sodium intake and plasma norepinephrine in patients with essential hypertension. Kidney Int. 1982;21:371-378. [Medline] [Order article via Infotrieve]
24. Feldman RD. Beta-adrenergic receptor alterations in hypertension: physiological and molecular correlates. Can J Physiol Pharmacol. 1987;65:1666-1672. [Medline] [Order article via Infotrieve]
25. Mark AL, Lawton WJ, Abboud FM, Fitz AE, Connor WE, Heistad DD. Effects of high and low sodium intake on arterial pressure and forearm vascular resistance in borderline hypertension. Circ Res. 1975;36-37(suppl I):I-194-I-198.
26.
Takeshita A, Imaizumi T, Ashihara T, Nakamura M.
Characteristics of responses to salt loading and deprivation in
hypertensive subjects. Circ Res. 1982;51:457-464.
27.
Sullivan JM, Ratts TE. Sodium sensitivity in
human subjects: hemodynamic and hormonal correlates.
Hypertension. 1988;11:717-723.
28.
Mills PJ, Dimsdale JE, Ziegler MG, Nelesen RA.
Racial differences in epinephrine and beta2-adrenergic
receptors. Hypertension. 1995;25:88-91.
29.
Kotanko P, Hoglinger O, Skrabal F.
Beta2-adrenoceptor density in fibroblast culture correlates with human
NaCl sensitivity. Am J Physiol. 1992;263:C623-C627.
30.
Avolio A. Genetic and environmental factors in
the function and structure of the arterial wall.
Hypertension. 1995;26:34-37.
31. Jackson CA, Insel PA. Renal alpha-adrenergic receptors and genetic hypertension. Pediatr Nephrol. 1993;7:853-858. [Medline] [Order article via Infotrieve]
32. Sun L, Schulte N, Pettinger P, Regan JW, Pettinger JW. The frequency of alpha2-adrenoceptor restriction fragment length polymorphisms in normotensive and hypertensive humans. J Hypertens. 1992;10:1011-1015. [Medline] [Order article via Infotrieve]
33.
Umemura S, Hirawa N, Iwamoto T, Yamaguchi S, Toya Y,
Kobayashi S, Takasaki I, Yasudi G, Tamura K, Ishii M, Sun L, Pettinger
W. Association analysis of restriction fragment length
polymorphism for
2-adrenergic receptor genes in essential
hypertension in Japan. Hypertension. 1994;23(suppl
I):I-203-I-206.
34. Lockette W, Ghosh S, Farrow S, MacKenzie S, Baker S, Miles AS, Cadaret L. Alpha2-adrenergic receptor gene polymorphism and hypertension in blacks. Am J Hypertens. 1995;8:390-394.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
B. C. Rossier and L. Schild Epithelial Sodium Channel: Mendelian Versus Essential Hypertension Hypertension, October 1, 2008; 52(4): 595 - 600. [Full Text] [PDF] |
||||
![]() |
L. Pojoga, N. S. Kolatkar, J. S. Williams, T. S. Perlstein, X. Jeunemaitre, N. J. Brown, P. N. Hopkins, B. A. Raby, and G. H. Williams {beta}-2 Adrenergic Receptor Diplotype Defines a Subset of Salt-Sensitive Hypertension Hypertension, November 1, 2006; 48(5): 892 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Eisenach, D. R. Schroeder, T. L. Pike, C. P. Johnson, W. G. Schrage, E. M. Snyder, B. D. Johnson, V. D. Garovic, S. T. Turner, and M. J. Joyner Dietary sodium restriction and {beta}2-adrenergic receptor polymorphism modulate cardiovascular function in humans J. Physiol., August 1, 2006; 574(3): 955 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Choi, S. Hong, R. Nelesen, W. A. Bardwell, L. Natarajan, C. Schubert, and J. E. Dimsdale Age and Ethnicity Differences in Short-Term Heart-Rate Variability Psychosom Med, May 1, 2006; 68(3): 421 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Peters Racism and Hypertension Among African Americans West J Nurs Res, October 1, 2004; 26(6): 612 - 631. [Abstract] [PDF] |
||||
![]() |
J. T. Wright Jr, M. Rahman, A. Scarpa, M. Fatholahi, V. Griffin, R. Jean-Baptiste, M. Islam, M. Eissa, S. White, and J. G. Douglas Determinants of Salt Sensitivity in Black and White Normotensive and Hypertensive Women Hypertension, December 1, 2003; 42(6): 1087 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Zion, V. Bond, R. G. Adams, D. Williams, R. E. Fullilove, R. P. Sloan, M. N. Bartels, J. A. Downey, and R. E. De Meersman Low arterial compliance in young African-American males Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H457 - H462. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Barlassina, C. Lanzani, P. Manunta, and G. Bianchi Genetics of Essential Hypertension: From Families to Genes J. Am. Soc. Nephrol., November 1, 2002; 13(90003): S155 - 164. [Abstract] [Full Text] |
||||
![]() |
T. A. Kotchen, U. Broeckel, C. E. Grim, P. Hamet, H. Jacob, M. L. Kaldunski, J. M. Kotchen, N. J. Schork, P. J. Tonellato, and A. W. Cowley Jr Identification of Hypertension-Related QTLs in African American Sib Pairs Hypertension, November 1, 2002; 40(5): 634 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Luft Molecular Genetics of Salt-Sensitivity and Hypertension Drug Metab. Dispos., April 1, 2001; 29(4): 500 - 504. [Abstract] [Full Text] |
||||
![]() |
N. Kato, T. Sugiyama, H. Morita, H. Kurihara, T. Sato, Y. Yamori, and Y. Yazaki Association Analysis of {beta}2-Adrenergic Receptor Polymorphisms With Hypertension in Japanese Hypertension, February 1, 2001; 37(2): 286 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hamet, N. Thorin-Trescases, P. Moreau, P. Dumas, B.-S. Tea, D. deBlois, V. Kren, M. Pravenec, J. Kunes, Y. Sun, et al. Workshop: Excess Growth and Apoptosis : Is Hypertension a Case of Accelerated Aging of Cardiovascular Cells? Hypertension, February 1, 2001; 37(2): 760 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Stein, C. C. Lang, I. Singh, H. B. He, and A. J. J. Wood Increased Vascular Adrenergic Vasoconstriction and Decreased Vasodilation in Blacks : Additive Mechanisms Leading to Enhanced Vascular Reactivity Hypertension, December 1, 2000; 36(6): 945 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Levy, A. L. DeStefano, M. G. Larson, C. J. O'Donnell, R. P. Lifton, H. Gavras, L. A. Cupples, and R. H. Myers Evidence for a Gene Influencing Blood Pressure on Chromosome 17 : Genome Scan Linkage Results for Longitudinal Blood Pressure Phenotypes in Subjects From the Framingham Heart Study Hypertension, October 1, 2000; 36(4): 477 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Agarwal, G. Giacchetti, G. Lavery, H. Nikkila, M. Palermo, M. Ricketts, C. McTernan, G. Bianchi, P. Manunta, P. Strazzullo, et al. CA-Repeat Polymorphism in Intron 1 of HSD11B2 : Effects on Gene Expression and Salt Sensitivity Hypertension, August 1, 2000; 36(2): 187 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. COWLEY JR., M. STOLL, A. S. GREENE, M. L. KALDUNSKI, R. J. ROMAN, P. J. TONELLATO, N. J. SCHORK, P. DUMAS, and H. J. JACOB Genetically defined risk of salt sensitivity in an intercross of Brown Norway and Dahl S rats Physiol Genomics, April 27, 2000; 2(3): 107 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Busjahn, G.-H. Li, H.-D. Faulhaber, M. Rosenthal, A. Becker, E. Jeschke, H. Schuster, B. Timmermann, M. R. Hoehe, and F. C. Luft {beta}-2 Adrenergic Receptor Gene Variations, Blood Pressure, and Heart Size in Normal Twins Hypertension, February 1, 2000; 35(2): 555 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dzimiri Regulation of beta -Adrenoceptor Signaling in Cardiac Function and Disease Pharmacol. Rev., September 1, 1999; 51(3): 465 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gratze, J. Fortin, R. Labugger, A. Binder, P. Kotanko, B. Timmermann, F. C Luft, M. R Hoehe, and F. Skrabal ß-2 Adrenergic Receptor Variants Affect Resting Blood Pressure and Agonist-Induced Vasodilation in Young Adult Caucasians Hypertension, June 1, 1999; 33(6): 1425 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takami, Z. Y. H. Wong, M. Stebbing, and S. B. Harrap Linkage analysis of glucocorticoid and beta 2-adrenergic receptor genes with blood pressure and body mass index Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1379 - H1384. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |